FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2334713027> ?p ?o ?g. }

• W2334713027 endingPage "1176" @default.
• W2334713027 startingPage "1163" @default.
• W2334713027 abstract "Abstract Acquired resistance to vemurafenib develops through reactivation of RAF/MEK/ERK signaling or bypass mechanisms. Recent combination therapies such as a MEK inhibitor combined with vemurafenib show improvement in major clinical end points, but the percentage of patients with adverse toxic events is higher than with vemurafenib monotherapy and most patients ultimately relapse. Therefore, there is an urgent need to develop new antimelanoma drugs and/or adjuvant agents for vemurafenib therapy. In this study, we created a novel semiorganically modified derivative, DETD-35, from deoxyelephantopin (DET), a plant sesquiterpene lactone demonstrated as an anti-inflammatory and anti–mammary tumor agent. Our results show that DETD-35 inhibited proliferation of a panel of melanoma cell lines, including acquired vemurafenib resistance A375 cells (A375-R) established in this study, with superior activities to DET and no cytotoxicity to normal melanocytes. DETD-35 suppressed tumor growth and reduced tumor mass as effectively as vemurafenib in A375 xenograft study. Furthermore, DETD-35 also reduced tumor growth in both acquired (A375-R) and intrinsic (A2058) vemurafenib resistance xenograft models, where vemurafenib showed no antitumor activity. Notably, the combination of DETD-35 and vemurafenib exhibited the most significant effects in both in vitro and in vivo xenograft studies due to synergism of the compound and the drug. Mechanistic studies suggested that DETD-35 overcame acquired vemurafenib resistance at least in part through deregulating MEK-ERK, Akt, and STAT3 signaling pathways and promoting apoptosis of cancer cells. Overall, our results suggest that DETD-35 may be useful as a therapeutic or adjuvant agent against BRAFV600E mutant and acquired vemurafenib resistance melanoma. Mol Cancer Ther; 15(6); 1163–76. ©2016 AACR." @default.
• W2334713027 created "2016-06-24" @default.
• W2334713027 creator A5005512198 @default.
• W2334713027 creator A5017190286 @default.
• W2334713027 creator A5030165416 @default.
• W2334713027 creator A5085200859 @default.
• W2334713027 date "2016-06-01" @default.
• W2334713027 modified "2023-09-26" @default.
• W2334713027 title "A Novel Plant Sesquiterpene Lactone Derivative, DETD-35, Suppresses BRAFV600E Mutant Melanoma Growth and Overcomes Acquired Vemurafenib Resistance in Mice" @default.
• W2334713027 cites W1217284267 @default.
• W2334713027 cites W1720078464 @default.
• W2334713027 cites W1777880594 @default.
• W2334713027 cites W1968530572 @default.
• W2334713027 cites W1970845550 @default.
• W2334713027 cites W1977326858 @default.
• W2334713027 cites W2032211985 @default.
• W2334713027 cites W2038264590 @default.
• W2334713027 cites W2041255253 @default.
• W2334713027 cites W2053473615 @default.
• W2334713027 cites W2055624262 @default.
• W2334713027 cites W2059972525 @default.
• W2334713027 cites W2065208438 @default.
• W2334713027 cites W2065385761 @default.
• W2334713027 cites W2080626878 @default.
• W2334713027 cites W2080866118 @default.
• W2334713027 cites W2096439168 @default.
• W2334713027 cites W2100614336 @default.
• W2334713027 cites W2116978375 @default.
• W2334713027 cites W2121797708 @default.
• W2334713027 cites W2126370176 @default.
• W2334713027 cites W2128542677 @default.
• W2334713027 cites W2128568558 @default.
• W2334713027 cites W2131040858 @default.
• W2334713027 cites W2141674733 @default.
• W2334713027 cites W2143811153 @default.
• W2334713027 cites W2154196978 @default.
• W2334713027 cites W2156078931 @default.
• W2334713027 cites W2163143576 @default.
• W2334713027 cites W2165091551 @default.
• W2334713027 cites W2170300037 @default.
• W2334713027 cites W2170552969 @default.
• W2334713027 cites W2308508407 @default.
• W2334713027 cites W2329695682 @default.
• W2334713027 cites W3146421254 @default.
• W2334713027 cites W4237979552 @default.
• W2334713027 cites W4245666978 @default.
• W2334713027 cites W4361741390 @default.
• W2334713027 doi "https://doi.org/10.1158/1535-7163.mct-15-0973" @default.
• W2334713027 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4893919" @default.
• W2334713027 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27048951" @default.
• W2334713027 hasPublicationYear "2016" @default.
• W2334713027 type Work @default.
• W2334713027 sameAs 2334713027 @default.
• W2334713027 citedByCount "18" @default.
• W2334713027 countsByYear W23347130272016 @default.
• W2334713027 countsByYear W23347130272017 @default.
• W2334713027 countsByYear W23347130272018 @default.
• W2334713027 countsByYear W23347130272019 @default.
• W2334713027 countsByYear W23347130272020 @default.
• W2334713027 countsByYear W23347130272021 @default.
• W2334713027 countsByYear W23347130272022 @default.
• W2334713027 crossrefType "journal-article" @default.
• W2334713027 hasAuthorship W2334713027A5005512198 @default.
• W2334713027 hasAuthorship W2334713027A5017190286 @default.
• W2334713027 hasAuthorship W2334713027A5030165416 @default.
• W2334713027 hasAuthorship W2334713027A5085200859 @default.
• W2334713027 hasBestOaLocation W23347130271 @default.
• W2334713027 hasConcept C104317684 @default.
• W2334713027 hasConcept C143065580 @default.
• W2334713027 hasConcept C150903083 @default.
• W2334713027 hasConcept C185592680 @default.
• W2334713027 hasConcept C207001950 @default.
• W2334713027 hasConcept C2776131300 @default.
• W2334713027 hasConcept C2776470698 @default.
• W2334713027 hasConcept C2777658100 @default.
• W2334713027 hasConcept C2994587330 @default.
• W2334713027 hasConcept C502942594 @default.
• W2334713027 hasConcept C55493867 @default.
• W2334713027 hasConcept C57074206 @default.
• W2334713027 hasConcept C62478195 @default.
• W2334713027 hasConcept C71924100 @default.
• W2334713027 hasConcept C86803240 @default.
• W2334713027 hasConcept C98274493 @default.
• W2334713027 hasConceptScore W2334713027C104317684 @default.
• W2334713027 hasConceptScore W2334713027C143065580 @default.
• W2334713027 hasConceptScore W2334713027C150903083 @default.
• W2334713027 hasConceptScore W2334713027C185592680 @default.
• W2334713027 hasConceptScore W2334713027C207001950 @default.
• W2334713027 hasConceptScore W2334713027C2776131300 @default.
• W2334713027 hasConceptScore W2334713027C2776470698 @default.
• W2334713027 hasConceptScore W2334713027C2777658100 @default.
• W2334713027 hasConceptScore W2334713027C2994587330 @default.
• W2334713027 hasConceptScore W2334713027C502942594 @default.
• W2334713027 hasConceptScore W2334713027C55493867 @default.
• W2334713027 hasConceptScore W2334713027C57074206 @default.
• W2334713027 hasConceptScore W2334713027C62478195 @default.
• W2334713027 hasConceptScore W2334713027C71924100 @default.
• W2334713027 hasConceptScore W2334713027C86803240 @default.

• next